Screener
Charles River Laboratories CRL Redeemable Noncontrolling Interest, Decrease from Redemptions or Purchase of Remaining Equity Interest
Redeemable Noncontrolling Interest, Decrease from Redemptions or Purchase of Remaining Equity Interest at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:RedeemableNoncontrollingInterestDecreaseFromRedemptionsOrPurchaseOfRemainingEquityInterest.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Redeemable Noncontrolling Interests | Common stock / Shares | Common stock / Amount | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock / Shares | Treasury Stock / Amount | Total Equity Attributableto Common Shareholders | Noncontrolling Interest | Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividends declared to noncontrolling interest | (2,378) | — | — | — | — | — | — | — | — | (1,645) | (1,645) |
| Adjustment of redeemable noncontrolling interests to redemption value | (5,694) | — | — | 5,694 | — | — | — | — | 5,694 | — | 5,694 |
| Purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (24,148) | — | — | — | — | — | — | — | — | — | — |
| Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (1,151) | — | — | 1,151 | — | — | — | — | 1,151 | — | 1,151 |
| Acquisition of redeemable noncontrolling interest | 45,374 | — | — | — | — | — | — | — | — | — | — |
| Issuance of stock under employee compensation plans | — | 499 | 5 | 25,592 | — | — | — | — | 25,597 | — | 25,597 |
| Purchase of treasury shares | — | — | — | — | — | — | 105 | (24,155) | (24,155) | — | (24,155) |
| Retirement of treasury shares | — | (105) | (1) | (3,847) | (20,307) | — | (105) | 24,155 | — | — | — |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest?
- Charles River Laboratories (CRL) reported redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest of -$287.75K in Q4 2023.
- What does redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest mean?
- Represents the decrease in redeemable noncontrolling interest equity due to the final settlement or purchase of remaining equity interests in a subsidiary.
Ask your AI about Charles River Laboratories's redeemable noncontrolling interest, decrease from redemptions or purchase of remaining equity interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude